Author: C. Michael White, Distinguished Professor of Pharmacy Practice, University of Connecticut

When it comes to drug pricing, the Trump and Biden-Harris administrations both have some very modest wins to tout. As director of the Health Outcomes, Policy, and Evidence Synthesis group at the University of Connecticut School of Pharmacy, I teach and study about the ethics of prescription drug prices and the complexities of drug pricing nationally. Delving into the presidential candidates’ successes on a number of drug-pricing policies, you’ll see a continuation of progress across the administrations. Neither the Trump administration nor the Biden-Harris administration, however, has done anything to truly lower drug prices for the majority of Americans. $35…